China's Syneron raises $150M for peptides, adding to last year's $100M
Syneron Bio said it raised a Series B round worth $150 million, which it will use to back the development of a drug class that's attracted growing interest because of its potential to borrow some ...
Original Source
Read the full article at Endpoints →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.